Adverse experiences in an Exosurf treated group.
Chatfield
S L
SL
Kelly
E J
EJ
Dear
P R
PR
D016022:Case-Control Studies; D004338:Drug Combinations; D005233:Fatty Alcohols / Q000009:adverse effects*; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy; D007231:Infant, Newborn; D007234:Infant, Premature; D010767:Phosphorylcholine; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011663:Pulmonary Surfactants / Q000009:adverse effects*; D016896:Treatment Outcome
D004338:Drug Combinations; D005233:Fatty Alcohols; D011663:Pulmonary Surfactants; D010767:Phosphorylcholine; D011092:Polyethylene Glycols; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination